We are delighted to announce that business solutions company, IPS, will be exhibiting and recruiting at Jobs Expo Dublin at Croke Park on April 28th.
IPS meets the needs of local and multinational clients by offering subject matter expertise and single-source EPCMV project delivery services worldwide.
IPS-Integrated Project Services, LLC (IPS) is a global leader in developing innovative business solutions for the pharmaceutical, biotechnology, Fast Moving Consumer Goods (FMCG), and medical device and diagnostics industries. Through operational expertise and industry-leading knowledge, skill and passion, IPS provides consulting, architecture, engineering, construction management, and compliance services that allow clients to create and manufacture life-impacting products around the world.
IPS’ European operations (IPS EMEA), headquartered in Birmingham, UK, is the premier full-service provider for IPS clients’ projects in Europe, Middle East, and Africa. In operation since 2015, IPS EMEA continues to rapidly expand its EPCMV project delivery capabilities to targeted industry sectors, including pharmaceutical and biotechnology. Its current portfolio of projects span several locations, including UK, Ireland, Germany, Denmark, the Netherlands, Austria, France, Spain, and Portugal.
With newly established Ireland operations, located in Dublin, IPS serves the growing number of projects and opportunities witnessed in the region. IPS leverages the strong pharmaceutical and biotechnology base in Ireland and uses the exceptionally skilled work-force in this country to serve their clients throughout the EMEA region.
IPS is a pioneer in the application of single-source, integrated EPCMV services for technically complex facilities. They have developed, implemented, and refined a lean delivery model that addresses the entire project life-cycle that focuses on design quality and effectively controls costs and schedule. IPS adds value by minimizing risk, reducing the duration from decision to delivery, and streamlining activities from concept to design to construction through commissioning and qualification. Specifically, services include:
- Technical Consulting / Strategic Business and Master Planning
- Architecture / Engineering
- Project Controls
- Construction Management
- Regulatory Consulting / Compliance CQV (Commissioning Qualification, Validation)
- Staffing Services
Implementing the services above, IPS leads projects for global organisations of all sizes that have project requirements of various scopes around their network. IPS is experienced at balancing the local country requirements, the local site standards and the overall company standards and expectations.
IPS is known for their deep expertise in the industry and their portfolio of Subject Matter Experts including technologists, process engineers, architects, building engineers, project management specialists, regulatory and compliance professionals, and business / operations consultants. Each possesses industry-operating experience and understands underlying technologies, industry trends, construction and EHS practices, regulatory environment and manufacturing processes to identify opportunities to streamline operations and maximise efficiency.
Join a Company whose Work Matters
At IPS, they know that the work they do matters – it creates a positive impact on everyday lives world-wide. Everyday, they exude pridein knowing that they are helping clients develop or manufacture products that improvelives.
IPS’ leadership recognises that if it were not for the hard work andcontributions of their employees, IPS would not be the great, successful, well-recognised and well-positionedcompany that they are today in the industry. In order togrow in strength and recognition, it is essential that they ensure and provide the right environment forgrowth of their valued employees.
IPS in Brief
Headquartered in Blue Bell, PA-USA, IPS is one of the fastest-growing companies servicing the life sciences industry with over 1,000 professionals in the US, Canada, Brazil, UK, Ireland, Switzerland, Singapore, China, and India.